Gregory Gorman | Author | SciTechnol | Journal of Pharmaceutical

Gregory Gorman Author

ggorman@samford.edu 205-726-4452 | 205-726-4452

Subjects of specialization
Chemotherapy, Temozolomide, Pathophysiology, Diagnostics, Picoplatin

Affiliation
Associate Professor, Director of Research, McWhorter School of Pharmacy, Samford University, USA

Biography

Gregory Gorman; Associate Professor, Director of Research, McWhorter School of Pharmacy, Samford University, USA. One of his references are, "Wingo PA, Reis LA, Giovino GA, Miller DS, Rosenberg HM, et al. (1999) Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91: 675-690."

Publications

Editorial Open Access

New and Emerging Strategies for the Treatment of Small Cell Lung Cancer

Author(s):

Gregory Gorman

New and Emerging Strategies for the Treatment of Small Cell Lung Cancer

Small Cell Lung Cancer (SCLC) is a very aggressive cancer that comprises 15 to 25% of all lung cancers and has its highest occurrence in smokers. Although it is generally considered to be very responsive to chemotherapy in the limited stage, it has a high incidence of recurrence. Despite its overall response rate which has been reported to be as high as 75 to 85%, patients with extensive s... view more»

DOI: 10.4172/2380-9477.1000e101

Abstract HTML PDF